Virtu Financial’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-378
| Closed | -$13K | – | 2297 |
|
|
2022
Q4 | $13K | Buy |
+378
| New | +$13K | ﹤0.01% | 1351 |
|
|
2022
Q2 | – | Sell |
-1,816
| Closed | -$452K | – | 2225 |
|
|
2022
Q1 | $452K | Buy |
1,816
+1,057
| +139% | +$263K | 0.03% | 428 |
|
|
2021
Q4 | $118K | Buy |
+759
| New | +$118K | 0.01% | 1064 |
|
|
2020
Q4 | – | Sell |
-405
| Closed | -$99K | – | 1891 |
|
|
2020
Q3 | $99K | Sell |
405
-77
| -16% | -$18.8K | 0.02% | 718 |
|
|
2020
Q2 | $139K | Buy |
+482
| New | +$139K | 0.02% | 802 |
|